Jennison Associates
ANAC

Jennison Associates’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Jennison Associates’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-507,404
Closed -$27.1M – 691
2016
Q1 		$27.1M Buy
507,404
+268,916
+113% +$19.9M 0.03% 373
2015
Q4 		$26.9M Buy
238,488
+63,942
+37% +$7.04M 0.03% 389
2015
Q3 		$20.5M Sell
174,546
-272,334
-61% -$35.6M 0.02% 432
2015
Q2 		$34.6M Sell
446,880
-317,017
-41% -$20.8M 0.03% 392
2015
Q1 		$44.2M Buy
763,897
+433,061
+131% +$18.4M 0.04% 346
2014
Q4 		$10.7M Buy
+330,836
New +$9.93M 0.01% 482
2014
Q3 		– Sell
-387,568
Closed -$6.87M – 787
2014
Q2 		$6.87M Hold
387,568
– – 0.01% 490
2014
Q1 		$7.75M Buy
387,568
+3,868
+1% +$75K 0.01% 500
2013
Q4 		$6.44M Buy
+383,700
New +$5.31M 0.01% 501

Other funds holding ANAC

KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Jennison Associates's ANAC Position: Q2 2016 in Review

Jennison Associates sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 507,404 shares — an estimated $27.1M sold.

Jennison Associates first reported a position in ANAC in Q4 2013 and held it in 9 quarters. The position peaked at $44.2M in Q1 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Jennison Associates reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Jennison Associates sold 507,404 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $27.1M.
  • Jennison Associates first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2013 and held it in 9 quarters.
  • Jennison Associates's ANACOR PHARMACEUTICALS INC COM position peaked at $44.2M in Q1 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Jennison Associates's 13F filing for Q2 2016, filed 3 Aug 2016.